Surrogate advertising of prescription drugs Selective enforcement of long-standing regulations #PharmaIndustry #GLP1 #DrugRegulation #IndianPharma #HealthcarePolicy #ObesityTreatment #PharmaMarketing #Trending #semaglutide To view or add a comment, sign in Hammurabi & Solomon Partners, Pharma & Healthcare Alerts:- CDSCO Advisory on GLP-1 Drugs (treatment of obesity and metabolic disorders) Compliance Checklist The CDSCOs recent advisory on GLP-1 drugs is a clear response to how aggressively these therapies are being positioned in India
Each is of the highest potency and purity, which ensures maximum absorption by the body
Injection site reactions including nodules, erythema, and pruritus occur in 10% to 20% of treated patients [69]
If it's cloudy, frozen or contains any particles, don't use it
The existence of a folate transporter in the human colonic cells has been demonstrated
Ive included their original disclosure and the information I discovered on openpayments when I wrote about that trial, as well as their disclosure for this study
